Aer Therapeutics Team
We are led by an experienced management team with an established track record of success in the development of drug-candidates.
![Irina Gitlin](https://aertherapeutics.com/wp-content/uploads/2022/05/Irina-Gitlin.jpg)
Irina Gitlin, PhD
Vice President, Research and Development
![Blair Capel](https://aertherapeutics.com/wp-content/uploads/2023/04/blair-1.jpg)
Blair Capel
Director of Finance
![Rony Nasrallah](https://aertherapeutics.com/wp-content/uploads/2023/04/rony-1.jpg)
Rony Nasrallah
Manager, Program Management
![Jordan Low](https://aertherapeutics.com/wp-content/uploads/2023/05/jordan.jpg)
Jordan Low
Director of Clinical Operations
Our Focus
Design and development of thiol-saccharides as safe and effective mucolytic agents with favorable properties for inhaled delivery. Utilization of state-of-the art lung imaging and analysis approaches to identify COPD and asthma patients with clinically silent airway mucus plugs and to measure efficacy of thiol-saccharide mucolytics.
![](https://aertherapeutics.com/wp-content/uploads/2023/03/man.jpg)